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   Metabolic syndrome and related disorders are increasingly prevalent in 
contemporary society, and thus pose the need for potent agents to control lipid 
accumulation in the body. This study indicates that Caenorhabditis elegans was 
effective in screening for potent lipid metabolism modulators with berberine as a 
model compound. Among the various isoquinoline alkaloids tested, sanguinarine, a 
benzophenanthridine alkaloid, was found to be the most potent. Sanguinarine, like 
berberine, reduced lipid accumulation through AMP-activated protein kinase 
activation. Analysis of AMPK (aak-1 and aak-2) RNAi worms revealed that effects 
were aak-2-dependent. Characterization of worms with knockdown nhr-49, a 
hormone nuclear receptor gene that functions as a key regulator of fat consumption, 
showed that both alkaloids were effective even in these markedly lipid-accumulating 
nhr-49 RNAi worms, suggesting that they predominantly affect lipid synthesis, 
rather than fatty acid β-oxidation. The versatility of C. elegans for the purpose of 
lipid-modulating chemical screening and characterization of the underlying 
mechanisms is discussed. 
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   Risk factors for metabolic syndrome, such as obesity, diabetes, and high blood 
pressure, are major concerns in modern society. To help reduce these health risks, 
many studies have been done to identify agents that can potently control the 
accumulation of lipids, which mediate metabolic syndrome. Several natural 
compounds, including catechin in green tea and capsaicin in chili pepper, have been 
reported to be good candidates.1, 2) 
In this study, we screened for more potent candidates among alkaloids, which 
exhibit strong pharmacological activities, and particularly isoquinoline alkaloids.  
Berberine, a benzylisoquinoline alkaloid that can be obtained from Berberis 
(Berberidaccae) and Coptis rhizomes, is used as an antibacterial agent in the 
treatment of gut infections and diarrhea. Recent reports on decreased plasma 
cholesterol and triglyceride levels in hypercholesterolemic patients, and reduced 
body weight and plasma triglyceride levels and improved insulin action in rats fed 
high-fat diets under treatment with berberine, suggest that it can be useful as a 
cholesterol-lowering drug.3) Furthermore, recent advances in the metabolic 
engineering of isoquinoline alkaloid biosynthesis, including both synthetic biology 
and chemical synthesis, have indicated that it might be possible to produce a wide 
array of alkaloids of this type.4, 5) 
In this study, we used Caenorhabditis elegans as a live model to detect the 
biological activities of isoquinoline alkaloids, since this worm offers several distinct 
advantages in preliminary screening, in terms of cost, time, and ease of manipulation, 
as well as effectiveness in gene-to-drug screening.6, 7) Furthermore, an intact animal 
offers advantages over in vitro or cell-based assays for subsequent application to the 
whole animal.8) In addition, C. elegans largely shares the core mechanisms of the 
regulatory pathways of mammalian energy homeostasis. The usefulness of C. 
elegans in screening small molecules to identify new regulators of fat storage has 
been demonstrated by Lemieux et al.9) 




modulator of lipid metabolism, and further screened several isoquinoline alkaloids 
for lipid metabolism-modulation activity. Among the isoquinoline alkaloids 
examined, sanguinarine had a greater effect on lipid accumulation than berberine. 
Since there are no previous reports to the effect that sanguinarine affects lipid 
metabolism or the insulin signaling pathway, except for a recent report that it directly 
activated AMP-activated protein kinase (AMPK),10) we examined the mechanism by 
which sanguinarine reduces lipid levels through the AMPK pathway, since there are 
various AMPK activators and AMPK activation mechanisms. 
AMPK functions as a fuel gauge, as it were, in biological systems, and is a 
prime target for new therapies for metabolic disorders, such as insulin resistance and 
type 2 diabetes.11) It is activated under conditions that deplete cellular ATP and 
elevate AMP levels. Recent studies have found that AMPK can also be activated by 
other stimuli that do not cause any detectable change in the AMP/ATP ratio, such as 
hyperosmotic stress and pharmacological agents like thiazolidinediones (TZD), 
metformin, and 5-aminoimidazole-4-carboxamide ribotide (AICAR). Upon 
activation, AMPK phosphorylates and inactivates several metabolic enzymes, that 
are involved in ATP-consuming pathways, including acetyl CoA carboxylase (ACC), 
fatty acid synthase, 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, and 
the mammalian target of rapamycin (mTOR), and activates ATP-generating 
processes such as fatty acid oxidation and glucose uptake (Supplemental Fig. 1; see 
Biosci. Biotechnol. Biochem. Web site). 
Since decreased lipid synthesis and increased lipid consumption in vivo should 
reduce lipid accumulation, we further investigated the involvement of fatty acid 
oxidation in the lipid-reducing effects of berberine and sanguinarine. The gene for a 
key regulator of fat consumption in C. elegans, nhr-49,12) was knocked down, and 
the effects of berberine and sanguinarine were examined. 
 




   Chemicals and reagents. Berberine sulfate was purchased from Tokyo Chemical 
Industry (Tokyo, Japan); AICAR from Wako Pure Chemicals (Osaka, Japan); 
sanguinarine chloride, alpha lipoic acid, and cholesterol from Sigma-Aldrich Japan 
(Tokyo, Japan); and magnoflorine, aromoline, tetrandrine, and isotetrandrine were 
the kind gift of Dr. K. Iwasa (Kobe Pharmaceutical University). 
Phospho-Thr172-AMPK and AMPK antibodies were from Cell Signaling 
Technology (Danvers, MA), and horseradish peroxide-conjugated donkey anti-rabbit 
IgG, from GE Healthcare Japan (Hino, Japan). All other reagents were purchased 
from Wako Pure Chemicals, unless otherwise stated. 
 
   Nematode strains. Wild type: N2 (Bristol) were maintained on nematode growth 
media (NGM) at 20°C by standard culture methods.13) 
 
   Nematode treatment. In preliminary screen by Nile Red staining, 3-d-old worms 
were used. When larger amounts of worms were required for Oil Red staining, and 
protein and RNA extraction, 2-d-old worms were used for treatment in subsequent 
assays to avoid a mixed population of adult worms, eggs, and larval L1 at the end of 
24 h of treatment. 
 
   Nile Red staining. Synchronized 3-d-old C. elegans were treated with various 
chemicals for 24 h on NGM medium plated with E. coli OP50 as food source and 50 
ng mL-1 of Nile Red (Sigma) and test compounds at the indicated final 
concentrations. Ten to 12 worms were treated in duplicate for each test compound in 
three independent experiments. After 24 h of culture at 20°C, 10 to 12 worms were 
randomly selected for observation against a bright field, and red fluorescence images 
were obtained by the Keyence BIOREVO BZ-9000 Imaging System (Keyence, 
Osaka, Japan). Hazy images were omitted, and the rest were used to quantify the 




(http://rsbweb.nih.gov/ij/). The results were verified by reproducibility in at least two 
of three independent experiments. The figures represent the results of one 
experiment. 
 
   Oil Red O staining. Two-d-old worms were treated with and without alkaloids (as 
control) for 24 h as in the Nile Red staining experiments. About 200-300 worms 
were collected and washed 3 times with 1X PBS pH 7.4 buffer.  Oil Red O staining 
was done as reported by O’ Rourke et al.14) After staining, 10 to 12 worms were 
selected randomly for observation under a bright field, and images were captured 
with a Keyence BIOREVO BZ-9000 Imaging System (Keyence). Hazy images were 
omitted, and the remaining ones were used to quantify the intensity of Oil Red O 
staining with ImageJ software. Each color image was separated into its RGB channel 
components, and the green channel was used for further analysis following the 
method of Yen et al.15) The results were verified by reproducibility in at least two of 
three independent experiments. The figures represent the results of one experiment. 
 
   RNA Interference. An RNAi feeding method16) was used. Some of the 
nucleotides of the coding regions of aak-1, aak-2, and nhr-49 complementary DNA 
were used for RNAi. The following primers were used: 
aak-1 forward, 5'-ATGCCTCCAAGTGGACGTTTCGATA-3'; aak-1 reverse, 
5'-CAGCAAGTAGAGCTCCAGTTACATC-3'; 
aak-2 forward, 5'-ATGTTTTCTCATCAAGATCGAGACCG -3'; aak-2 reverse, 
5'-TACAACTTTCCGCTAATAACCTCAGG-3'; 
nhr-49 forward, 5'-ATGGACCTAGTAGATCCTCTTG-3'; and nhr-49 reverse, 
5'-AGAGGATGAATTGCCAATGGAG-3'. 
   The primers were fused with restriction enzyme sites. Xba1 and Xho1 for aak-1 
and aak-2, and Xba1 and Xma1 for nhr-49 and were used to amplify the genes of 




A. Fire, Stanford University) with the various restriction sites and transformed into 
HT115 bacterial cells. Colonies were screened, and positive transformants were 
confirmed by PCR with the original primer pairs. RNAi control worms were fed 
bacteria carrying an empty pL4440 vector. The details of the procedures for RNAi 
treatment are described in Supplemental Information. 
 
   Immunoblot analysis. Two-d-old C. elegans were treated with 1 mM of various 
chemicals for 24 h on NGM medium plated with E. coli OP50 as food source. 
Procedures for immunoblot analysis are described in Supplemental Information. 
 
   Quantitative RT–PCR. Total RNA was extracted with Sepasol-RNA I Super G 
(Nacalai Tesque, Kyoto, Japan), purified with an RNeasy Mini Kit (Qiagen Japan, 
Tokyo, Japan), and reverse-transcribed into cDNA with SuperScript III reverse 
transcriptase (Invitrogen, Carlsbad, CA) with oligo(dT) primer. cDNA (final 
concentration, 500 pg µL-1) was subjected to qRT-PCR analysis by the CFX96 
Real-Time PCR System (Bio-Rad, Hercules, CA) with IQ SYBR Green Super Mix 
(Bio-Rad). The conditions for the PCR reactions were 95°C for 15 min, followed by 
40 cycles of 95 °C for 10 s, 60°C for 20 s, and 72°C for 20 s. Melting curve analysis 
was done after each run at 72°C to 95°C to check the specificity of amplification. 
Data were analyzed with Bio-Rad CFX Manager (Bio-Rad) Version 1.5. The number 
of transcripts in a sample was determined by comparing the number of cycles (c) 
required for the reaction to reach a common threshold (t). The relative amount of 
transcript between samples was further standardized by amplification of cdc-42 as 
internal control. 
   Sequences of forward and reverse primers used in quantitative RT-PCR analysis 
were as follows: 





acs-2 forward, 5'-TGACGTGCTCAAGTCTCCAC-3'; acs-2 reverse, 
5'-CTTCACCATCTTCTCGCACA-3'; 
cpt-5 forward, 5'-TGCGATGGAGCTGAGTTAGA-3'; cpt-5 reverse, 
5'-GTGACAGTCGCAATCTCCAA-3'; 
cdc-42 forward, 5'-AGCTTCATTCGAGAATGTCC-3'; and cdc-42 reverse, 
5'-CTCGAGCATTCCTGGATCAT-3'. 
 
   Statistical analysis. Statistical comparisons between groups were evaluated by 
ANOVA, followed by Dunnett`s multiple comparisons test for measurements of Nile 
Red fluorescence and Oil Red O staining intensity, and for qRT-PCR analysis. 
Differences were considered to be significant at p < 0.05. Error bars represent 
standard deviation unless otherwise stated. 
 
Results and Discussion 
   Nile Red and Oil Red O staining revealed the effects of isoquinoline alkaloids on 
lipid accumulation in the treated worms 
In preliminary experiments, we examined the effect of berberine, a known 
lipid modulator, by Nile Red staining9,17) and confirmed that it has a lipid-reducing 
effect. We further validated the effect of berberine by Oil Red O stain, since it is a 
more accurate proxy for major fat stores in the subcellular compartments of the 
worm.14) 
Next we examined the effects of several other isoquinoline alkaloids 
(sanguinarine, magnoflorine, isotetrandrine, tetrandrine, and aromoline), by Nile Red 
stain. AICAR, an AMP mimetic nucleoside commonly used to activate AMPK, and 
alpha lipoic acid, which improves hypertriglyceridemia by stimulating triacylglycerol 
clearance and downregulating liver triacylglycerol secretion, were selected as 
reference lipid-reducing agents.18,19) 
Treatment of worms with berberine, sanguinarine, and AICAR at 1 mM 




significantly reduced lipid accumulation, while treatment with alpha lipoic acid only 
slightly reduced lipid accumulation. The other alkaloids produced little or no 
reduction in fluorescence at concentrations of up to 5 mM (Fig. 2A and B). All the 
worms showed normal growth and mobility during the 24-h treatment period. 
The lipid-reducing effect of sanguinarine was further verified by Oil Red O 
stain (Fig. 2C and D). Due to the limited availability of some chemicals, we 
confirmed only that magnoflorine and tetrandrine did not have lipid-reducing effects 
by Oil Red O stain (Supplemental Fig. 2). Sanguinarine exhibited much stronger 
lipid-reducing activity than berberine. It significantly reduced lipid accumulation at a 
concentration (25 µM) almost 20-fold lower than the effective concentration of 
berberine (Fig. 3 and Supplemental Fig. 3). 
 
   Sanguinarine induced phosphorylation of AMPK 
The AMPK pathway has been reported to be involved in the regulation of fat 
metabolism for berberine-induced fat reduction,18) in which the inhibition of ACC in 
HepG2 cells resulted in inhibition of cholesterol and triglyceride synthesis.20) We 
further characterized the effects of sanguinarine on AMPK and its downstream 
molecules in comparison with the effects of berberine.  
To determine the conditions for activation of AMPK, we checked its 
phosphorylation conditions with anti-phospho AMPK (pAMPK)-specific antibody. 
Treatment with sanguinarine and AICAR induced the phosphorylation of AMPK 
(Fig. 4), whereas berberine had only a marginal effect, but phosphorylation of 
AMPK by treatment with berberine has been reported.20,21) A possible explanation 
for the weak phosphorylation detected in our experiments is the lower reaction 
specificity of the antibody against C. elegans proteins, since previously we detected 
phosphorylation of AMPK induced by berberine in HepG2 cells (data not shown). 
 






that aak-2 is involved in the mechanisms by which berberine and sanguinarine 
modulate lipids 
To investigate the mechanisms by which berberine and sanguinarine reduced 
lipid levels in the treated worms, we knocked down the genes encoding the C. 
elegans homologs of the catalytic α-subunits of AMPK, aak-1, and aak-2. AAK-1 
and AAK-2 are 40% and 52% identical to and share 71% and 80% amino acid 
identity respectively with the kinase domain of human AMPKα subunits. They also 
contain a conserved critical threonine residue, the phosphorylation of which is 
required for AMPK activation.11) The function of AAK-1 has not been much 
characterized, except for a study by Lemieux et al.9) in which they identified an 
undisclosed compound, F17, that activated AMPK signaling in C. elegans via aak-1. 
When aak-1 or aak-2 was knocked down by RNA interference (RNAi) with 
double-stranded RNA of these genes, lipid levels were reduced by berberine and 
sanguinarine in the aak-1 RNAi worms, while there was little response in the aak-2 
RNAi worms (Fig. 5A and B), which suggests that AMPK, and especially aak-2, 
plays an important role in the lipid reduction induced by berberine and sanguinarine. 
Quantitative real-time PCR (qRT-PCR) analysis of the transcripts of aak-1 and aak-2 
in the aak-1 RNAi worms indicated that aak-2 expression was induced roughly in 
proportion to reduction in aak-1 (Supplemental Fig. 4A). On the other hand, the 
aak-1 transcript level was unaffected in the aak-2 RNAi worms (Supplemental Fig. 
4B). These results suggest that AMPKα subunit expression in the worms was 
regulated mainly by aak-2, that accounts for most of the basal activity and activation 
by berberine and sanguinarine. Li et al.22) have reported that the α1 and α2 isoforms 
of the catalytic AMPK subunits in most tissues of the ischemic rat heart can be 
differentially activated due to different sensitivities to small changes in the AMP 
concentration. Our results suggest that in this worm, the aak-1 isoform of the 






   Sanguinarine was effective at reducing lipid levels in the high-fat worms with a 
deficient β-oxidation pathway 
While nuclear hormone receptor NHR-49 in C. elegans is highly homologous 
to hepatocyte nuclear factor 4 (HNF4) in mammals, it is functionally more similar to 
mammalian peroxisome proliferator-activated receptors (PPARs). NHR-49 
modulates fat-consumption pathways as a key regulator of fat usage, and maintains 
the fatty acid saturation in balance. It targets multiple enzymes involved in 
transporting fatty acids across the mitochondrial membrane for β-oxidation. Hence, 
nhr-49 knockout exhibited a high-fat phenotype due to deficiencies in two metabolic 
pathways: fatty acid β-oxidation and fatty acid desaturation.12) 
We conducted an RNAi experiment on nhr-49 and investigated the 
involvement of β-oxidation in lipid-reduction by berberine and sanguinarine. 
Consistently with the reported high-fat phenotype, the nhr-49i worms showed 
increased fat storage under Oil Red O staining (Fig. 6A and B, Supplemental Fig. 5). 
They showed a marked increase in body size and significantly lower expression of 
mitochondrial β-oxidation genes, ech-1 (encodes a mitochondrial β-oxidation 
trifunctional enzyme), cpt-5 (encodes a carnitine palmitoyl transferase), and acs-2 
(encodes a mitochondrial acyl-CoA synthetase) (Fig. 6C).  NHRs respond to 
lipophilic molecules, regulating the expression of target genes involved in 
metabolism, reproduction, and development.17) Liang et al.23) have reported that 
NHR-64, another C. elegans HNF4 nuclear receptor, regulates fat storage, growth, 
and brood size in these worms. 
Despite their high fat accumulation, the nhr-49 knockdown worms were 
sensitive to berberine and sanguinarine, suggesting that both alkaloids act 
independently of nhr-49 (Fig. 6A). Unexpectedly, an analysis of nhr-49 transcript 
levels in RNAi control worms (pL4440) treated with berberine and sanguinarine 
showed reduced nhr-49 expression (Fig. 6D), albeit to a lesser extent than for nhr-49 





lipid synthesis (via AMPK) and degradation (via NHR-49) are not clear, inhibition of 
lipid biosynthesis through AMPK activation had a greater effect on lipid 
accumulation. 
 
   Effects of plant alkaloids on lipid modulation and the mechanisms 
In our primary screening of isoquinoline alkaloids, protoberberine (berberine)- 
and benzophenanthridine (sanguinarine)- type compounds showed lipid-reducing 
activity, while other types of isoquinoline alkaloids, including aporphine 
(magnoflorine)- and bisbenzylisoquinoline (isotetrandrine, tetrandrine, 
aromoline)-ones, did not. Screening of metabolically modified plant cell extracts 
consisting of protoberberine and benzophenanthridine alkaloids can provide useful 
information on the most bioactive alkaloids as drug leads. Preliminary screening of 
plant cell extracts in the ongoing study suggested that a cell extract is more potent 
than a single compound such as sanguinarine (data not shown). Cell extracts can 
have multiple cellular targets and effects that are probably due to multiple 
interactions of the quaternary nitrogen, and polycyclic and planar structures with 
nucleophilic and anionic moieties of amino acids in biomacromolecules.24) 
Whereas both berberine and sanguinarine are potent lipid modulators, these 
two compounds have different chemical structures and points of efficacy. Our 
biochemical and RNAi experiments indicate that their effects are dependent on 
AMPK and enhanced AMPK phosphorylation, which control several metabolic 
processes including lipid metabolism. AMPK is stimulated by AMP through 
allosteric activation of phosphorylated AMPK and by inhibition of the 
dephosphorylation of its Thr-172 by protein phosphatases.25) These effects are due to 
the binding of AMP at two exchangeable sites on the γ- subunits, and are opposed by 
ATP, which binds at the same sites. AMPK activation might also be the result of 
direct binding to AMPK at sites distinct from that of AMP, as reported for chemicals 




Plant alkaloids perhaps defend against herbivores and pathogens. Many 
alkaloids have been reported to be mitochondrial inhibitors and might also be potent 
AMPK activators.27) Activation of AMPK by berberine and sanguinarine might be 
the result of inhibition of ATP synthesis and an increase in the AMP level based on 
the finding that these alkaloids inhibited mitochondrial respiration.21) Studies of cell 
lines that express AMPK complexes bearing an R531G mutation, which renders γ2 
complexes insensitive to increases in ADP and AMP, have indicated that berberine 
works by increasing cellular AMP or ADP. On the other hand, Choi et al.10) reported 
that sanguinarine directly interacted with AMPK and enhanced its activity to a level 
above that mediated by AMP. 
It would be interesting to investigate the difference between indirect and direct 
AMPK activation and its implications for the potency of alkaloid bioactivity. 
Although both berberine and sanguinarine activate AMPK, the difference in the 
uptake efficiency of these chemicals should also be considered, since Turner et al.21) 
have reported greater absorption of dihydroberberine as compared to berberine due to 
the structural modification.  
Besides reductions in lipid synthesis, increments in lipid consumption might 
also decrease lipid accumulation in an organism. We investigated this with nhr-49 
knockdown worms. Our nhr-49 RNAi experiment showed reduced lipid 
accumulation under berberine and sanguinarine treatment (Fig. 6A), while nhr-49 
expression was also reduced in the control worms treated with both alkaloids (Fig. 
6D). NHR-49 acts as a positive regulator of acs-2 and ech-1 promoting fatty acid 
oxidation by mitochondria. Pathare et al. 28) have reported that NHR-49 activated and 
repressed genes in multiple lipid metabolism pathways. Thus knockdown of nhr-49 
can lead to high lipid accumulation (Fig. 6A and B). Our results suggest that 
berberine and sanguinarine have antagonistic actions on and lipid synthesis (via 
AMPK activation) and oxidation (via NHR-49 downregulation) processes. The 




that lipid biosynthesis regulated by AMPK activation predominates over the 
downregulated lipid degradation process due to nhr-49 (Supplemental Fig. 1).  
 
   Versatility of the worm 
The results of this study confirm the feasibility of using C. elegans for 
bioactivity screening of plant isoquinoline alkaloids. One of the advantages of C. 
elegans is that about 40% of the genes associated with human therapeutical targets 
have homologs in the worm, which makes it a good model for studying drug-target 
interaction and target validation. This worm has been instrumental in elucidating 
important aspects of several important receptor-based pathways that regulate energy 
storage and utilization, including insulin, serotonin, TGF-β, and adiponectin. 29)   
We have used a combination of genetic and biochemical approaches to 
characterize the lipid metabolism modulation effects of plant alkaloids. In this study, 
we confirmed that the lipid-reducing activity of sanguinarine is linked to the AMPK 
signaling pathway and not dependent on the NHR-49 pathway, similarly to berberine 
(Figs. 4-6). Whereas most previous studies of AMPK activation used liver cells of 
rodents or another mammalian model, our study indicates that C. elegans can also be 
used. These findings are advantageous for bioactivity screening, since they expand 
the scope of the worm in multiple assays beyond preliminary screening. Promising 
candidate compounds can be later validated in mammalian models, and this might 
ultimately reduce the overall cost of drug development.  
Although C. elegans can serve well as a screening model, the effective 
concentration of berberine (400 µM) in this worm to reduce lipid accumulation was 
much higher than the effective concentration (7 µM) reported for a human 
hepatoma-derived cell, the HepG2 cell.3) This difference might be due to the 
potential difference in the target sites, and also to different absorption and/or 
degradation ability of those cells for berberine. Sanguinarine showed higher lipid 




concentration is very close to the EC50 value (26 to 28 µM) that activated human 
recombinant AMPK in an in vitro assay.10) Our preliminary experiments with the 
nhr-8 RNAi worm with a knocked-down xenobiotic response, which showed 
enhanced sensitivity to berberine, may provide clues to understanding the differences 
between the uptake and metabolism of berberine and sanguinarine in vivo (Chow and 
Sato, in preparation).  
Moreover, screening in an intact worm makes it possible simultaneously to 
monitor toxicity, which is not possible in an in vitro assay. For instance, besides 
lipid-reducing effects, berberine and sanguinarine also have cytotoxic activity, 
similarly to many plant alkaloids. These chemicals were known to form complexes 
with DNA and RNA, and to inhibit telomerase and topoisomerase.30) Sanguinarine 
exhibited both stronger lipid-reducing activity and stronger cytotoxicity 
(Supplemental Fig. 6). Separation of the cytotoxic effects from the desired 
lipid-reducing activity for sanguinarine and related alkaloids is crucial for 
therapeutical applications. 
In this study, we screened for bioactivities in pure, isolated compounds. As has 
been demonstrated in most ethnobotanical or traditional medicine applications, 
therapeutic effects are often produced by a concoction of plant extracts. Our future 
studies will incorporate extracts from medicinal plant cells, including metabolically 
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Fig. 1.  Structures of Test Compounds. 
 
Fig. 2.  Effects of Isoquinoline Alkaloids on Lipid Accumulation.  
   (A) Nile Red staining in treated worms. Berberine, sanguinarine, AICAR, and 
alpha lipoic acid were administered at 1 mM. Magnoflorine, isotetrandrine, 
tetrandrine, and aromoline were administered at concentration of 5 mM. Images show 
typical results in worms treated with the test compounds for 24 h. Magnification is 
40× for the top row and 20× for the bottom row (Scale bar, 100 µm); exposure time, 
1/25 s; light intensity, 40%. n, 10 each for three independent experiments.  (B) 
Quantification of Nile Red fluorescence intensity in treated worms with ImageJ 
software; average values are shown for the compounds tested (see “Materials and 
Methods”) and normalized to the control sample. (C) Oil Red O staining in treated 
worms. Images show typical results for worms treated with berberine or sanguinarine 
for 24 h. Magnification at 10× (Scale bar, 100 µm). (D) Quantification of Oil Red O 
staining intensity in treated worms by ImageJ. Average values are shown for the 
compounds tested and these are normalized to the control sample. *p < 0.05 
(ANOVA followed by Dunnett`s test) for the (B) and (D). C, control in (B) and (D). 
 
Fig. 3. Effects of Berberine (A) and Sanguinarine (B) on Lipid Accumulation in 
Worms.  
   Quantification of Oil Red O staining intensity using ImageJ. Values are averages 
of 10-12 images for the compounds tested and these are normalized to the control 
sample; *p < 0.05 (ANOVA followed by Dunnett`s test). C, control in (A) and (B). 
 





   They were treated with berberine, sanguinarine, or AICAR at 1 mM for 24 h. (A) 
Representative immunoblots of worm protein extracts for anti-phospho AMPKα and 
anti-AMPKα are shown. (B) Average phosphorylation levels of AMPK for three 
independent experiments were quantified by ImageJ based on band intensities, and 
normalized to total AMPK levels in the control worms. *p < 0.05 (ANOVA followed 
by Dunnett`s test). C, control. 
 
Fig. 5. Knockdown of the C. elegans Homologs of Catalytic α-Subunits of AMPK.  
   Relative intensity of Oil Red O-stained lipid droplets quantified by ImageJ in (A) 
aak-1 and (B) aak-2 RNAi worms treated for 24 h with berberine, B at 200 µM or 
400 µM and sanguinarine, S at 25 µM. n, 10-12 for the compounds tested; *p < 0.05 
(ANOVA followed by Dunnett`s test). pL4440, RNAi vector control. aak-1i, aak-1 
RNAi worms. aak-2i, aak-2 RNAi worms. 
 
Fig. 6. Effects of Alkaloid Treatment on nhr-49 RNAi Worms.  
   (A) Relative intensity of Oil Red O-stained lipid droplets quantified by ImageJ in 
nhr-49 RNAi worms treated with berberine, B (400 µM) or sanguinarine, S (25 µM) 
for 24 h. C is non-treated control; n, 10-12 for the compounds tested; *p < 0.05 
(ANOVA followed by Dunnett`s test). (B) Oil Red O staining of RNAi control 
worms and nhr-49 RNAi worms. Images show typical results for worms at a 
magnification of 20× (scale bar, 100 µm). qRT-PCR showed the expression of 
fatty-acid oxidation genes (C), and nhr-49 gene (D). The mRNA abundance value 
represents the average of triplicate cDNA templates applied to qRT-PCR, and the 
results were normalized to cdc-42. p < 0.05 (ANOVA followed by Dunnett`s test). 
pL4440, RNAi vector control. nhr-49i, nhr-49 RNAi worms. Results were verified 
by reproducibility in at least two of three independent experiments. 
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Supplemental Figure 1 
Scheme showing the effects of AMPK activation on the lipid metabolism pathway.  
When AMPK is activated, it phosphorylates and inactivates several metabolic enzymes 
involved in ATP-consuming pathways such as acetyl-CoA carboxylase (ACC), fatty acid 
synthase, and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase.  The inhibition of 
ACC leads to the decreased conversion of acetyl-CoA to malonyl-CoA, which 
subsequently activates carnitine palmitoyl transferase (CPT). CPT transports long-chain 
acyl-CoAs into the mitochondrial matrix for beta oxidation, which eventually enters the 
citric acid cycle and generates ATP molecules. 
      The C. elegans genes included in this study are shown in blue italics. aak-1 and aak-2 
are homologs of the catalytic α-subunits of AMPK in the worm.  nhr-49 encodes a C. 
elegans nuclear hormone receptor which serves as a key regulator of fat consumption by 
targeting several enzymes that are  involved in mitochondrial β-oxidation, including 































Tetrandrine 1mM Magnoflorine 1mM Control 
Supplemental Figure 2 
(A) Oil Red O staining in treated worms. Images show representative results in worms
 after treatment with magnoflorine or tetrandrine for 24 h. Magnification at 20x (scale bar, 
 100 µm). n, 10-12 each from 3 independent experiments.  
(B) Quantification of the intensity of Oil Red O staining in treated worms using ImageJ
 software (http://rsbweb.nih.gov/ij/).  Values are the average of 10-12 images for each








































Supplemental Figure 3 
Oil Red O staining in worms treated with (A) berberine and (B) sanguinarine for 24 h.





































Supplemental Figure 4 
Quantitative RT-PCR of aak-1 and aak-2 transcript levels in (A) aak-1 and (B) aak-2
 RNAi worms. mRNA abundance values represent the average of triplicate cDNA
 templates applied to run qRT-PCR and the results were normalized against cdc-42 as
 an internal control. Results were verified by reproducibility in at least two of three
 independent experiments and representative results from one experiment are shown.
 *p < 0.05, **p < 0.005, two-tailed t-test. pL4440 – RNAi vector control, aak-1i –
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Supplemental Figure 5 
Oil Red O staining in (A) RNAi vector control, pL4440, and (B) nhr-49i worms treated
 with berberine or sanguinarine for 24 h.  Magnification at 20x (scale bar, 100 µm). n,
 10-12 each from 3 independent experiments. 
Berberine 
 400 µM 
Sanguinarine 
 25 µM 
Supplemental Figure 6 
Survival rate of C. elegans after treatment with berberine or sanguinarine monitored
 until 50% mortality. Results shown as average of two independent experiments.
 Error bar indicates standard deviation; n, 120. 
Supplemental Methods 
RNA Interference.  HT115 bacteria containing an RNAi vector or control vector were 
grown in Luria-Bertani (LB) broth with 25 µg mL-1 carbenicillin overnight at 37°C, and 
induced with 1mM isopropyl-b-D-thiogalactopyranoside (IPTG) for the final 3 h. The 
bacterial culture was pelleted and resuspended in the same volume of S-medium with 
added 1 mM IPTG and 25 µg mL-1 carbenicillin, and 500 µL was dispensed into each 
well of a 24-well plate. Two synchronized L3 larval worms were added to each well. 
Plates were incubated at 20°C for 3 d, during which period the worms would have laid 
eggs that then hatched and grew to the L3 larval stage. Two-d-old worms were treated 
with the test compounds in 500 µL of S-medium with fresh HT115 RNAi bacteria 
culture, 1 mM IPTG and 25 µg mL-1 carbenicillin per well. The plates were incubated at 
20°C for 24 h and RNAi worms that had been treated with the same test compound were 
combined (24-wells). Worms were washed in M9 1X buffer and subjected to the 
measurement of Oil Red O staining intensity, or protein or RNA extraction. 
Immunoblot Analysis. The nematodes were collected and washed with M9 1X buffer. 
After M9 buffer was removed, 50 µL of nematode sample was dispensed into Eppendorf 
tubes, protease inhibitor cocktail (Calbiochem) was added, and protein was extracted 
with 1X Sample buffer (50 mM Tris-HCl pH 6.8, 2% SDS, 6% 2-mercaptoethanol, 10% 
glycerol, 0.01% bromophenol blue, distilled water). Protein concentrations were 
determined by the Bradford method and, for each sample, 20 µg protein was loaded and 
separated by SDS-PAGE. Proteins were electro-transferred onto a polyvinylidene 
difluoride membrane (PVDF) (Millipore Immobilon-P) and probed with phospho-
Thr172-AMPK [1/2000x dilution in 5% BSA/Tris buffered saline with Tween-20 
(TBST)], followed by HRP-conjugatedsecondary donkey anti-rabbit IgG (1/5000x 
dilution in 5%BSA/TBST) and chemiluminescence was detected using ImageQuant 
LAS4010 (GE Healthcare Life Sciences). Blots were then stripped and reprobed with 
AMPK (1/2000x dilution in 5%BSA/TBST) and subjected to chemiluminescence 
detection as with phospho-specific antibody. 
Survival Rate. Twenty adult nematodes were placed onto each 6-cm NGM medium 
plated with E. coli OP50 as food source and alkaloids at the indicated concentration for 
each plate. Survival rate monitoring commenced on “Day 0 after treatment” until 50% of 
the worm population in each treatment were dead. Live worms were counted and 
transferred to new NGM + OP50 plates with same alkaloid concentration every 2 d. 
Worms that did not respond to light touch with a platinum wire picker were considered 
dead.  
